CodeMap® Compliance Briefing: April 16, 2020
Editor's Welcome: Coding and reimbursement information concerning COVID-19 testing seems to continually evolve and/or change. Late last week, the American Medical Association (AMA) CPT® Editorial Panel convened a second special meeting to approve codes specific for reporting COVID-19 antibody testing. During the April 10 meeting, the panel revised one procedure code and established two additional procedure codes to provide increased specificity to report serologic laboratory testing for COVID-19. These developments are explained in today's CodeMap® Compliance Briefing.
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2022 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.